U.S. Overdose Deaths Decline for Third Straight Year, Return to Pre-Pandemic Levels
Similar Articles
U.S. Drinking Rate in 2025 Hits Lowest Level Since 1939
Violent Crime Declines Across Major U.S. Cities in Early 2026
Teen Drinking Rates Hit Historic Lows After Decades-Long Decline
CDC Finds Over 30% of U.S. Adults Get Insufficient Sleep
Cannabis Use Among Older Adults Rises as Potency and Health Risks Increase
Preliminary federal data shows U.S. drug overdose deaths fell by about 14% in 2025, marking the third consecutive annual decline and the longest such drop in decades. The 2025 total of roughly 70,000 deaths is approximately equal to the 2019 pre-pandemic level. While deaths declined overall, some states saw increases, and new, potent synthetic drugs continue to emerge.
Facts First
- U.S. overdose deaths fell for a third straight year in 2025, with a roughly 14% decline to about 70,000.
- The 2025 total is near 2019's pre-pandemic level, after deaths peaked at nearly 110,000 in 2022.
- Deaths declined across several drug types, including fentanyl, cocaine, and methamphetamine.
- Some states reported increases in overdose deaths, including Arizona, Colorado, and New Mexico.
- New synthetic drugs continue to be identified, including potent opioids like cyclorphine.
What Happened
Preliminary data from the CDC shows U.S. drug overdose deaths declined for the third consecutive year in 2025, the longest such decline in decades. The 2025 total of about 70,000 deaths is approximately 14% lower than the previous year and is roughly equal to the total recorded in 2019, before the COVID-19 pandemic. Overdose deaths had peaked at nearly 110,000 in 2022. The CDC reported declines across several drug types, including fentanyl, cocaine, and methamphetamine. However, some states, including Arizona, Colorado, and New Mexico, reported notable increases in overdose deaths.
Why this Matters to You
This sustained decline in overdose deaths suggests that public health efforts to address the crisis may be having a measurable effect, which could mean fewer families and communities will experience this specific loss. The return to pre-pandemic fatality levels, while still high, marks a significant shift from the peak of the crisis. However, the emergence of new, more potent synthetic drugs like cyclorphine—a synthetic opioid described as up to 10 times stronger than fentanyl—means the drug supply remains unpredictable and dangerous. If you or someone you know uses drugs, the risk of encountering an unknown, lethal substance may be increasing even as overall death rates fall.
What's Next
The federal government's approach to the overdose crisis appears to be shifting. The SAMHSA recently notified grant recipients that the government will no longer pay for test strips and kits used to detect lethal additives in drugs. Officials are moving away from funding services like clean syringes and drug-use hotlines, which they view as facilitating illicit drug use. This policy change could affect the availability of harm reduction tools in many communities. Meanwhile, researchers at the CFSRE continue to identify new synthetic drugs at a rapid pace, finding 23 new substances in less than five months of 2026, which suggests the illicit drug market is continuing to evolve.